Result of Everolimus Treatment on Fibrosis Progression in Maintenance Liver Transplant Patients with Recurrent Hepatitis C

被引：0

作者：

Villamil, F. ^{[1
]}

Gadano, A. ^{[2
]}

Zingale, F. ^{[3
]}

Perez, R. ^{[4
]}

Gil, O. ^{[10
]}

Yantorno, S. ^{[5
]}

Mastai, R. ^{[6
]}

Otero, A. ^{[7
]}

Dong, G. ^{[8
]}

Lopez, P. ^{[9
]}

机构：

[1] British Hosp Buenos Aires, Liver Transplant Unit, Buenos Aires, DF, Argentina

[2] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina

[3] Inst Cardiovasc Rosario, Rosario, Argentina

[4] Hosp Italiano Mendoza, Mendoza, Argentina

[5] Fdn Favaloro, Buenos Aires, DF, Argentina

[6] Hosp Aleman, Buenos Aires, DF, Argentina

[7] Novartis Pharmaceut, Buenos Aires, DF, Argentina

[8] Novartis Pharmaceut, E Hanover, NJ USA

[9] Novartis Pharma AG, Basel, Switzerland

[10] Hepato Gastronterol, Cordoba, Argentina

来源：

关键词：

D O I：

10.1097/00007890-201211271-00014

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

1575

引用

页码：9 / 9

页数：1